Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
NCT01495715 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2014-08-22
Summary
The objective of the study is to determine whether administration of idebenone can shorten the time to improvement of visual acuity in patients with chronic vision loss due to LHON.
Conditions
- Leber's Hereditary Optic Neuropathy
Interventions
- DRUG
-
Idebenone
- DRUG
Sponsors & Collaborators
-
Santhera Pharmaceuticals
lead INDUSTRY
Eligibility
- Min Age
- 10 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Observational Study of Vision Improvement in Patients With Retinal Disorders
NCT04693702 ·Status: COMPLETED
-
Luminopia One Amblyopia Vision Improvement Study
NCT03608150 ·Status: COMPLETED ·Phase: NA
-
Levodopa for the Treatment of Residual Amblyopia
NCT01190813 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate QR-110 in Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
NCT03140969 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Light-Blocking Lenses on Pediatric Hyperopia
NCT07142915 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exploring Perceptual Learning in Blurred Gabor Discrimination for Low-Myopic Children
NCT07107646 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
NCT04101721 ·Status: COMPLETED ·Phase: PHASE3
-
Home-based Visual Training in Patients Implanted With Trifocal Diffractive Intraocular Lenses
NCT04985097 ·Status: COMPLETED ·Phase: NA
-
Safety & Efficacy of the Laser Scleral Microporation Procedure (Taiwan)
NCT04151446 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
NCT03913143 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Genomewide Screening of Pathological Myopia
NCT00155753 ·Status: UNKNOWN
-
Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers
NCT03166072 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Shanghai Eye Study for Adults
NCT03455478 ·Status: RECRUITING ·Phase: NA
-
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
NCT06927414 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa
NCT01530659 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic Subjects
NCT06075576 ·Status: COMPLETED
-
Monovision for the Treatment of Diplopia
NCT01426672 ·Status: COMPLETED ·Phase: PHASE1
-
Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults
NCT04657172 ·Status: COMPLETED ·Phase: PHASE3
-
Spectacle Lens Visual Acuity Assessments Study
NCT05650190 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Low-Level Monochromatic Red-Light for High Myopia Control in Adults
NCT05947019 ·Status: UNKNOWN ·Phase: NA
-
A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia.
NCT04806503 ·Status: TERMINATED ·Phase: PHASE2
-
A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
NCT03201562 ·Status: COMPLETED ·Phase: PHASE2
-
First-Sight Refractive Error Correction in the Developing World
NCT01598818 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
NCT02516306 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of RP and LCA by Primary RPE Transplantation
NCT03566147 ·Status: UNKNOWN ·Phase: EARLY_PHASE1